aod9604 human clinical trials weight loss results AOD-9604 Trial & FDA Status (2026) Weight loss peptides for fat
Description
Does AOD-9604 affect blood sugar, insulin, or growth hormone levels
2Draw your chosen amount of bacteriostatic water and inject it slowly down the inner wall of the AOD-9604 + CJC-1295 + Ipamorelin vial
Continuous Use There is limited research on optimal cycling strategies (periods of use followed by breaks) versus continuous use
AOD-9604 works in the body on adipose tissue, also known as body fat tissue
Most patients notice initial metabolic shifts such as changes in energy or early body composition feedback within two to four weeks
No dose-escalation or maximum tolerated dose studies have been conducted, limiting understanding of safety at higher doses
